AI assistant
AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2019
May 31, 2019
31580_dirs_2019-05-31_4f20f078-9fe2-4d93-9d66-6bab7a2e488b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2019-05-29
Reporting Person: Clancy Paul J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-05-31 | Common stock | M | 1400 | — | Acquired | 1400 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-29 | Stock option (right to buy) | $47.91 | A | 8919 | Acquired | 2029-05-29 | Common stock (8919) | Direct |
| 2019-05-29 | Restricted stock units | $ | A | 1878 | Acquired | Common stock (1878) | Direct | |
| 2019-05-31 | Restricted stock units | $ | M | 1400 | Disposed | Common stock (1400) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2: This option was granted on May 29, 2019. The shares underlying this option vest as to 100% of the underlying shares on May 29, 2020.
F3: The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
F4: The restricted stock units were granted on May 31, 2018. The shares underlying the stock units vested in full on May 31, 2019. Vested shares will be delivered to the reporting person within three business days after such shares become vested.